On September 1, 2022 BCI Pharma reported that it will attend the XXVII EFMC International Symposium on Medicinal Chemistry in Nice from September 4-8, 2022 and present its promising research program targeting tumor-associated macrophages (Press release, BCI Pharma, SEP 1, 2022, View Source [SID1234621935]). Mode of action and efficacy data of its preclinical candidate will be discussed (Press release, BCI Pharma, SEP 1, 2022, View Source [SID1234621935]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!